With new diabetes drug data, Eli Lilly is taking aim at obesity - STAT
Eli Lilly Stock Gets Bump After Drug Trial Positive Results
Lilly's new weight-loss drug is a 'double wow' and likely blockbuster – Indianapolis Business Journal
Type 2 Diabetes Drug Tirzepatide on Fast Track for Weight Loss
FDA Approves Mounjaro, a Novel Once-a-Week Medication to Treat Type 2 Diabetes | Everyday Health
Eli Lilly's new diabetes drug Mounjaro priced below Novo Nordisk's Wegovy (NYSE:LLY) | Seeking Alpha
SVB Securities: Eli Lilly's new diabetes drug could boost the stock, says SVB Securities - The Economic Times
Eli Lilly's diabetes portfolio grows with FDA nod for projected blockbuster drug - MedCity News
Blood sugar drug tirzepatide also leads to substantial weight loss in diabetes patients, Eli Lilly says | CNN
Eli Lilly weight loss drug for type-2 diabetes approved by the FDA
New Diabetes Drug Shows Sharply Reduced Risk of Heart-Related Death - WSJ
Obesity and Alzheimer's news makes Eli Lilly world's most valuable drugmaker | The Japan Times
Eli Lilly's new weight loss drug could eclipse Ozempic as the most powerful treatment | BenefitsPRO
Lilly's Diabetes Drug Fuels Wall Street Enthusiasm for Shares - BNN Bloomberg
People with diabetes lost up to 34 pounds taking Eli Lilly drug, company says
Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesity - MarketWatch
Trulicity's ascent lifts Lilly - PMLiVE
What to know about the new weight loss drug tirzepatide. Will it be affordable?
Lilly Doesn't Expect to Meet Near-Term Demand for Diabetes Drug | SupplyChainBrain
Lilly diabetes drug could bring $10B to diverse blockbuster pipeline – analysts | S&P Global Market Intelligence
Novo Nordisk's New Type 2 Diabetes Drug Outperforms Eli Lilly's
How promising are new drugs to treat obesity and who should — and shouldn't — use them? Our medical analyst explains | News Channel 3-12
Eli Lilly's Says Inventory For Diabetes Mounjaro Is Available, Probably Ending Shortage
/cloudfront-us-east-2.images.arcpublishing.com/reuters/X5JXZK6PSBOJDMB6PMVLQVQ6PU.jpg "U.S. FDA approves Eli Lilly's treatment for type 2 diabetes | Reuters")
U.S. FDA approves Eli Lilly's treatment for type 2 diabetes | Reuters
Eli Lilly: New diabetes drug tirzepatide could be most effective weight-loss method for type 2 diabetes yet | PerthNow
Eli Lilly weight loss drug tirzepatide data released
Mounjaro diabetes drug by Lilly wins FDA blessing | Fierce Pharma
U.S. FDA flags shortage of Eli Lilly's new diabetes drug - Mounjaro, ET HealthWorld
